LONDON--(BUSINESS WIRE)--Technavio has been monitoring the glaucoma surgery devices market and it is poised to grow by USD 1.53 billion during 2020-2024, progressing at a CAGR of almost 31% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Please Request Free Sample Report on COVID-19 Impact
Frequently Asked Questions-
- What was the value of the glaucoma surgery devices market in 2019?
- Technavio says that the value of the market was USD 0.53 billion in 2019 and it is projected to reach USD 2.06 billion by 2024.
- At what CAGR is the market projected to grow during the forecast period 2020-2024?
- Growing at a CAGR of almost 31%, the market growth will accelerate in the forecast period.
- What is the key factor driving the market?
- Increasing prevalence of glaucoma is one of the key factors driving the market growth.
- Who are the top players in the market?
- Alcon Inc., Allergan Plc, Carl Zeiss Meditec AG, Ellex Medical Lasers Ltd., Glaukos Corp., IRIDEX Corp., Johnson & Johnson, Lumenis Ltd., Santen Pharmaceutical Co. Ltd., and Sight Sciences Inc. are some of the major market participants.
- Which region is expected to hold the highest market share?
- North America
- What is the major trend in the market?
- Increasing adoption of SLT as primary therapy is a trend driving the market growth.
The market is concentrated, and the degree of concentration will accelerate during the forecast period. Alcon Inc., Allergan Plc, Carl Zeiss Meditec AG, Ellex Medical Lasers Ltd., Glaukos Corp., IRIDEX Corp., Johnson & Johnson, Lumenis Ltd., Santen Pharmaceutical Co. Ltd., and Sight Sciences Inc. are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The increasing prevalence of glaucoma has been instrumental in driving the growth of the market.
Glaucoma Surgery Devices Market 2020-2024: Segmentation
Glaucoma Surgery Devices Market is segmented as below:
-
Product
- MIGS Devices
- Laser Therapy Devices
- Conventional Therapy Devices
-
Geographic Landscape
- North America
- Europe
- Asia
- ROW
To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR41528
Glaucoma Surgery Devices Market 2020-2024: Scope
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our glaucoma surgery devices market report covers the following areas:
- Glaucoma Surgery Devices Market size
- Glaucoma Surgery Devices Market trends
- Glaucoma Surgery Devices Market analysis
This study identifies the increasing adoption of SLT as primary therapy as one of the prime reasons driving the glaucoma surgery devices market growth during the next few years.
Glaucoma Surgery Devices Market 2020-2024: Vendor Analysis
We provide a detailed analysis of vendors operating in the glaucoma surgery devices market, including some of the vendors such as Alcon Inc., Allergan Plc, Carl Zeiss Meditec AG, Ellex Medical Lasers Ltd., Glaukos Corp., IRIDEX Corp., Johnson & Johnson, Lumenis Ltd., Santen Pharmaceutical Co. Ltd., and Sight Sciences Inc. Backed with competitive intelligence and benchmarking, our research reports on the glaucoma surgery devices market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.
Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform
Glaucoma Surgery Devices Market 2020-2024: Key Highlights
- CAGR of the market during the forecast period 2020-2024
- Detailed information on factors that will assist glaucoma surgery devices market growth during the next five years
- Estimation of the glaucoma surgery devices market size and its contribution to the parent market
- Predictions on upcoming trends and changes in consumer behavior
- The growth of the glaucoma surgery devices market
- Analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of glaucoma surgery devices market vendors
Table of Contents:
Executive Summary
- Market Overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Product
- Market segments
- Comparison by Product placement
- MIGS devices - Market size and forecast 2019-2024
- Laser therapy devices - Market size and forecast 2019-2024
- Conventional therapy devices - Market size and forecast 2019-2024
- Market opportunity by Product
Customer Landscape
- Overview
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2019-2024
- Europe - Market size and forecast 2019-2024
- Asia - Market size and forecast 2019-2024
- ROW - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
Drivers, Challenges, and Trends
- Market drivers
- Volume driver - Demand led growth
- Volume driver - Supply led growth
- Volume driver - External factors
- Volume driver - Demand shift in adjacent markets
- Price driver - Inflation
- Price driver - Shift from lower to higher-priced units
- Market challenges
- Market trends
Vendor Landscape
- Overview
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Alcon Inc.
- Allergan Plc
- Carl Zeiss Meditec AG
- Ellex Medical Lasers Ltd.
- Glaukos Corp.
- IRIDEX Corp.
- Johnson & Johnson
- Lumenis Ltd.
- Santen Pharmaceutical Co. Ltd.
- Sight Sciences Inc.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
